Abstract
Androgen deprivation therapy has become the mainstay treatment for locally advanced and metastatic prostate cancer. Castrate testosterone levels can be achieved by a multitude of treatments. We performed a medline literature search to answer the question, is there a “best” endocrine treatment? In conclusion we found that the “best” endocrine therapy for advanced prostate cancer is complete androgen blockade (CAB) with a luteinizing hormone-releasing hormone (LHRH) agonist and a nonsteroidal antiandrogen.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gheiler, E., Tiguert, R. Current concepts in androgen deprivation therapy – is there a “best” endocrine treatment?. World J Urol 18, 190–193 (2000). https://doi.org/10.1007/s003459900099
Issue Date:
DOI: https://doi.org/10.1007/s003459900099